Last $1.34 HKD
Change Today -0.03 / -2.19%
Volume 1.6M
3332 On Other Exchanges
Hong Kong
As of 4:01 AM 09/30/14 All times are local (Market data is delayed by at least 15 minutes).

nanjing sinolife united co-h (3332) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/15/14 - $2.89
52 Week Low
09/2/14 - $1.25
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NANJING SINOLIFE UNITED CO-H (3332)

Related News

No related news articles were found.

nanjing sinolife united co-h (3332) Related Businessweek News

No Related Businessweek News Found

nanjing sinolife united co-h (3332) Details

Nanjing Sinolife United Company Limited is engaged in the manufacture, sale, and retail of nutritional supplements and health food products. It is also involved in the import and retail of third-party branded Australian nutritional food products, such as macadamia oil, avocado oil, balsamic vinegar, honey products and jams, as well as gifts. The company offers its products under the Zhongsheng, Keda, Guishi, Cobayer, Conbair, C, and CoKanga brands. In addition, it is engaged in the trading of food products. As of June 30, 2013, the company operated 49 self-managed retail stores consisting of 35 Zhongsheng retail stores and 14 Cobayer retail stores located in 25 cities covering 8 provinces and centrally administered municipalities in the People’s Republic of China. Nanjing Sinolife United Company Limited also sells its Cobayer series products through, an online shopping platform. The company was founded in 1999 and is headquartered in Nanjing, the People’s Republic of China.

577 Employees
Last Reported Date: 08/28/14
Founded in 1999

nanjing sinolife united co-h (3332) Top Compensated Officers

Chief Executive Officer, General Manager and ...
Total Annual Compensation: CNY279.0K
Chief Production Officer, Executive Director ...
Total Annual Compensation: CNY135.0K
Total Annual Compensation: CNY134.0K
Chairman of the Board of Supervisors and Cust...
Total Annual Compensation: CNY132.0K
Employee representative Supervisor
Total Annual Compensation: CNY78.0K
Compensation as of Fiscal Year 2013.

nanjing sinolife united co-h (3332) Key Developments

Nanjing Sinolife United Company Limited Announces Unaudited Consolidated Financial Results for the Six Months Ended June 30, 2014; Provides Earnings Guidance for the Second Half of 2014

Nanjing Sinolife United Company Limited announced unaudited consolidated financial results for the six months ended June 30, 2014. For the period, the company reported turnover of RMB 95.981 million against RMB 85.965 million a year ago. Profit before income tax was RMB 42.823 million against RMB 40.278 million a year ago. Profit for the period was RMB 32.804 million or RMB 0.04 per diluted share against RMB 29.700 million or RMB 0.05 per diluted share a year ago. The Group invested approximately RMB 2.4 million in the first half of 2014 against RMB 6.2 million a year ago, for purchase of property, plant and equipment. Barring unforeseen circumstances, the Group is optimistic about its performance in the second half of 2014.

Nanjing Sinolife United Company Limited Omits to Pay Interim Dividend for the Six Months Ended 30 June 2014

The Board of Nanjing Sinolife United Company Limited proposed not to declare any interim dividend for the six months ended 30 June 2014 compared to RMB 26 million paid a year ago.

Nanjing Sinolife United Company Limited Enters into Cooperation Agreement with COFCO Nutritional Health Research Institute Co., Ltd

On 30 June 2014, Nanjing Sinolife United Company Limited entered into a cooperation agreement with COFCO Nutritional Health Research Institute Co. Ltd. (COFCO). Pursuant to the cooperation agreement, the company and COFCO have agreed to, among others, cooperate in the research and development of nutritional products and establish a long-term relationship as strategic cooperation partners. The cooperation agreement includes the following principal terms: COFCO would share with the Company its latest product development and research results, and the company could, based on its evaluation, apply those results in the commercialization of nutritional products. The intellectual property rights of such nutritional products would be solely owned by COFCO. The company can seek assistance from COFOC to conduct specific research and development work on certain potential nutritional products based on its understanding of the market condition and assessment of feasibility. The intellectual property rights of such products would be jointly owned by the Company and COFOC. The company and COFCO may jointly launch the COFCO-Sinolife Nutritional Supermarket project in the future when consider appropriate to promote quality nutritional products throughout the PRC, the mode of operation and implementation details of which are to be determined. The company and COFCO would jointly establish a research centre to develop nutritional supplements. The Company would invest in the establishment of the research centre and COFCO would provide technical guidance and assistance in research and development. Research results would be shared by both the company and COFCO. The Cooperation Agreement would be for a term of five years, with effect from July 1, 2014 to June 30, 2019. The board considers that the cooperation agreement will enhance the group's overall competitiveness in the nutritional supplements industry in the PRC by broadening and enriching the group's potential product candidates, and strengthening the group's research and development capability. This would assist the group in achieving better operational and financial performance, which will be beneficial to the group and the shareholders of the company as a whole.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3332:HK $1.34 HKD -0.03

3332 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Besunyen Holdings Co Ltd $0.64 HKD -0.03
By-health Co Ltd CNY29.31 CNY +0.36
Real Nutriceutical Group Ltd $2.64 HKD -0.03
Unisplendour Guhan Group Co Ltd CNY16.40 CNY -0.01
Zhejiang Medicine Co Ltd CNY11.01 CNY +0.25
View Industry Companies

Industry Analysis


Industry Average

Valuation 3332 Industry Range
Price/Earnings 10.6x
Price/Sales 4.4x
Price/Book 1.7x
Price/Cash Flow 12.4x
TEV/Sales 1.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANJING SINOLIFE UNITED CO-H, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at